Brought to you by 
Intradigm raises $16mm through Series A financing
27 Nov 2006
Executive Summary
Intradigm (drug discovery in RNAi therapeutics) raised $16mm from its Series A financing round. Alta Partners and Frazier Healthcare Ventures co-led and were joined by existing investors Emerging Technology Partners and Novartis Ventures Fund, as well new supporters MediBic Alliance/Daiichi investment fund and Genentech.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Macromolecule
-
Drug Delivery
-
Biotechnology
- Antisense, Oligonucleotides
- Gene Therapy, Cell Therapy
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Intradigm raises $16mm through Series A financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice